ConductScience.org, home

Paper7350435

Oral hydralazine therapy for primary pulmonary hypertension.

Rubin LJ and 1 other. N Engl J Med, 1980. Cited by 248 papers, by iCite.

Cite this record

ConductScience Library. Oral hydralazine therapy for primary pulmonary hypertension. Papers, record 7350435. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7350435

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Oral hydralazine therapy for primary pulmonary hypertension.
PubMed
Journal
N Engl J Med
PubMed
Year
1980
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
248
iCite
Relative citation ratio, by iCite
11.6
iCite
Revised in PubMed
2013-11-21
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Rubin LJL J
2Peter RHR H

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
HydralazineMajor topic
Hypertension, PulmonaryMajor topic
Administration, Oral
Adult
Blood Pressure
Cardiac Catheterization
Cardiac Output
Female
Heart Rate
Hemodynamics
Humans
Male
Middle Aged
Oxygen
Oxygen Consumption
Physical Exertion
Vascular Resistance

Source PubMed

Download CSV of topics

Cited by35

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 248 citations.

PMIDTitleJournalYearIn PapersSource
40013009How a Most Unlikely Drug Changed the Outcome of Pulmonary Arterial Hypertension.Pulm Circ2025https://conductscience.org/library/papers/40013009PubMed
39980709Introducing Historical Vignettes in Pulmonary Circulation.Pulm Circ2025https://conductscience.org/library/papers/39980709PubMed
39906119Pulmonary Hypertension: A Personal Journey.Pulm Circ2025https://conductscience.org/library/papers/39906119PubMed
34422153Pulmonary Vascular Response Patterns to Exercise: Is there a Role for Pulmonary Arterial Pressure Assessment during Exercise in the Post-Dana Point Era?Adv Pulm Hypertens2010https://conductscience.org/library/papers/34422153PubMed
32180938Pulmonary vasodilation in acute pulmonary embolism - a systematic review.Pulm Circ2020https://conductscience.org/library/papers/32180938PubMed
28632001Vasodilator responsiveness in idiopathic pulmonary arterial hypertension: identifying a distinct phenotype with distinct physiology and distinct prognosis.Pulm Circ2017https://conductscience.org/library/papers/28632001PubMed
22974762Iron chelation inhibits the development of pulmonary vascular remodeling.Free Radic Biol Med2012https://conductscience.org/library/papers/22974762PubMed
7451649Influence of prostaglandin synthesis inhibitors on pulmonary vasodilatory effects of hydralazine in dogs with hypoxic pulmonary vasoconstriction.J Clin Invest1981https://conductscience.org/library/papers/7451649PubMed
7442300Primary pulmonary hypertension: modern approaches to an old problem.Lung1980https://conductscience.org/library/papers/7442300PubMed
7442081[Comparison of oral diazoxide and minoxidil in refractory hypertension].Klin Wochenschr1980https://conductscience.org/library/papers/7442081PubMed
7272141Primary pulmonary hypertension: effects of nifedipine.Br Heart J1981https://conductscience.org/library/papers/7272141PubMed
7188437Corticosteroid responsive pulmonary hypertension in systemic lupus erythematosus.Clin Rheumatol1982https://conductscience.org/library/papers/7188437PubMed
7128637Hemodynamic effects of sodium nitroprusside in patients with ventricular septal defect.Eur J Pediatr1982https://conductscience.org/library/papers/7128637PubMed
7107172Vasodilator therapy of pulmonary hypertension in the CRST syndrome.Ir J Med Sci1982https://conductscience.org/library/papers/7107172PubMed
7022422Effects of captopril (SQ 14,225) in a patient with primary pulmonary hypertension.Postgrad Med J1981https://conductscience.org/library/papers/7022422PubMed
6821608Ambulatory monitoring of pulmonary artery pressure. A preliminary clinical evaluation.Br Heart J1983https://conductscience.org/library/papers/6821608PubMed
6786460Remission of primary pulmonary hypertension during treatment with diazoxide.Br Med J (Clin Res Ed)1981https://conductscience.org/library/papers/6786460PubMed
6782123Pulmonary vasodilator responses to nitroprusside and nitroglycerin in the dog.J Clin Invest1981https://conductscience.org/library/papers/6782123PubMed
6743418Detrimental effects of verapamil in patients with primary pulmonary hypertension.Br Heart J1984https://conductscience.org/library/papers/6743418PubMed
6704262Continuous recording of pulmonary artery pressure in unrestricted subjects.Br Heart J1984https://conductscience.org/library/papers/6704262PubMed

See all 35 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7350435

GET https://conductscience.org/api/papers/v1/7350435/cited_by?page=2